6 trends shaping pharma strategies in 2024
Life sciences leaders like you must contend with changes to your customer’s business reality and its implications for their own success while also addressing changes and pressures along the pharmaceutical value chain. This year will prove pivotal in the long-term success of pharma and biotech companies as you develop organization-wide strategies inclusive of real-world data (RWD) for the next 12 to 18 months.
That’s why life sciences market experts from Optum® and Advisory Board came together once again to offer their take on 6 trends shaping pharmaceutical manufacturer strategies in 2024.
Watch the on-demand webinar now.